Výsledky vyhledávání

Akademický článek

A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.

Autor: Abuzakhm SM; OhioHealth, Columbus, Ohio, USA., Sukrithan V; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Fruth B; Mayo Clinic, Rochester, Minnesota, USA., Qin R; Janssen Pharmaceuticals, Raritan, New Jersey, USA., Strosberg J; H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA., Hobday TJ; Mayo Clinic, Rochester, Minnesota, USA., Semrad T; Tahoe Forest Cancer Center, Truckee, California, USA., Reidy-Lagunes D; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Kindler HL; University of Chicago Medical Center, Chicago, Illinois, USA., Kim GP; George Washington University Cancer Center, Washington, DC, USA., Knox JJ; Princess Margaret Cancer Centre, Toronto, ON, Canada., Kaubisch A; Montefiore Medical Center, Bronx, New York, USA., Villalona-Calero M; City of Hope, Duarte, California, USA., Chen H; CTEP National Cancer Institute, Bethesda, Maryland, USA., Erlichman C; Mayo Clinic, Rochester, Minnesota, USA., Shah MH; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.

Publikováno v: Endocrine-related cancer [Endocr Relat Cancer] 2023 Sep 13; Vol. 30 (11). Date of Electronic Publication: 2023 Sep 13 (Print Publication: 2023).

Zobrazit plný text záznamu

Phase i trial of arginine deprivation therapy with ADI-PEG 20 plus docetaxel in patients with advanced malignant solid tumors

Autor: Tomlinson, BK, Thomson, JA, Bomalaski, JS, Diaz, M, Akande, T, Mahaffey, N, Li, T, Dutia, MP, Kelly, K, Gong, IY, Semrad, T, Gandara, DR, Pan, CX, Lara, PN

Publikováno v: Tomlinson, BK; Thomson, JA; Bomalaski, JS; Diaz, M; Akande, T; Mahaffey, N; et al.(2015). Phase i trial of arginine deprivation therapy with ADI-PEG 20 plus docetaxel in patients with advanced malignant solid tumors. Clinical Cancer Research, 21(11), 2480-2486. doi: 10.1158/1078-0432.CCR-14-2610. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/88q9k237

© 2015 AACR. Purpose: This phase I study examined the toxicity and tolerability of pegylated arginine deiminase (ADI-PEG 20) in combination with docetaxel in patients with advanced solid malignancies. Experimental Design: Eligible patients had histo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::bab2984c0d3032c38b2ae12c34e1b79d
http://www.escholarship.org/uc/item/88q9k237

Zobrazit plný text záznamu

Akademický článek

Identification and Application of Emerging Biomarkers in Treatment of Non-Small-Cell Lung Cancer: Systematic Review.

Autor: Restrepo, Juan Carlos¹ (AUTHOR) juan.restrepo16@usc.edu.co, Martínez Guevara, Darly¹ (AUTHOR) darly.martinez00@usc.edu.co, Pareja López, Andrés² (AUTHOR) apareja@ces.edu.co, Montenegro Palacios, John Fernando³ (AUTHOR) john.montenegro00@usc.edu.co, Liscano, Yamil¹ (AUTHOR) yamil.liscano00@usc.edu.co

Publikováno v: Cancers. Jul2024, Vol. 16 Issue 13, p2338. 37p.

Zobrazit plný text záznamu

Akademický článek

Autor: Lynch E; Department of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA., Semrad T; Department of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA., Belsito VS; Department of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA., FitzGibbons C; Department of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA., Reilly M; Department of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA., Hayakawa K; Department of Toxicology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime 794-8555, Japan., Suzuki M; Department of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA masatoshi.suzuki@wisc.edu.; Stem Cell and Regenerative Medicine Center, University of Wisconsin-Madison, Madison, WI 53706, USA.

Publikováno v: Disease models & mechanisms [Dis Model Mech] 2019 Aug 16; Vol. 12 (8). Date of Electronic Publication: 2019 Aug 16.

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Significant Clinical Response to a MEK Inhibitor Therapy in a Patient With Metastatic Melanoma Harboring an RAF1 Fusion.

Autor: Kim KB; Kevin B. Kim, Mark Singer, and Mohammed Kashani-Sabet, California Pacific Medical Center Research Institute, San Francisco; Thomas Semrad, Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA; Alexa B. Schrock, Siraj M. Ali, and Jeffrey S. Ross, Foundation Medicine, Cambridge, MA; and Jeffrey S. Ross, Albany Medical College, Albany, NY., Semrad T; Kevin B. Kim, Mark Singer, and Mohammed Kashani-Sabet, California Pacific Medical Center Research Institute, San Francisco; Thomas Semrad, Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA; Alexa B. Schrock, Siraj M. Ali, and Jeffrey S. Ross, Foundation Medicine, Cambridge, MA; and Jeffrey S. Ross, Albany Medical College, Albany, NY., Schrock AB; Kevin B. Kim, Mark Singer, and Mohammed Kashani-Sabet, California Pacific Medical Center Research Institute, San Francisco; Thomas Semrad, Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA; Alexa B. Schrock, Siraj M. Ali, and Jeffrey S. Ross, Foundation Medicine, Cambridge, MA; and Jeffrey S. Ross, Albany Medical College, Albany, NY., Ali SM; Kevin B. Kim, Mark Singer, and Mohammed Kashani-Sabet, California Pacific Medical Center Research Institute, San Francisco; Thomas Semrad, Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA; Alexa B. Schrock, Siraj M. Ali, and Jeffrey S. Ross, Foundation Medicine, Cambridge, MA; and Jeffrey S. Ross, Albany Medical College, Albany, NY., Ross JS; Kevin B. Kim, Mark Singer, and Mohammed Kashani-Sabet, California Pacific Medical Center Research Institute, San Francisco; Thomas Semrad, Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA; Alexa B. Schrock, Siraj M. Ali, and Jeffrey S. Ross, Foundation Medicine, Cambridge, MA; and Jeffrey S. Ross, Albany Medical College, Albany, NY., Singer M; Kevin B. Kim, Mark Singer, and Mohammed Kashani-Sabet, California Pacific Medical Center Research Institute, San Francisco; Thomas Semrad, Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA; Alexa B. Schrock, Siraj M. Ali, and Jeffrey S. Ross, Foundation Medicine, Cambridge, MA; and Jeffrey S. Ross, Albany Medical College, Albany, NY., Kashani-Sabet M; Kevin B. Kim, Mark Singer, and Mohammed Kashani-Sabet, California Pacific Medical Center Research Institute, San Francisco; Thomas Semrad, Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA; Alexa B. Schrock, Siraj M. Ali, and Jeffrey S. Ross, Foundation Medicine, Cambridge, MA; and Jeffrey S. Ross, Albany Medical College, Albany, NY.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2018 Nov; Vol. 2, pp. 1-6.

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

P1:06 PHASE I STUDY OF THE COMBINATION OF ALISERTIB (MLN8237) AND GEMCITABINE IN ADVANCED SOLID TUMORS

Autor: Semrad, T.¹ (AUTHOR), Kelly, K.¹ (AUTHOR), Gandara, D.¹ (AUTHOR), Riess, J.¹ (AUTHOR), Li, T.¹ (AUTHOR), Yu, A.¹ (AUTHOR), Mack, P.¹ (AUTHOR), Kim, E.¹ (AUTHOR)

Publikováno v: Annals of Oncology. 2015 Supplement, Vol. 26, pii16-ii19. 4p.

Zobrazit plný text záznamu

Akademický článek

Are there disparities in the presentation, treatment and outcomes of patients diagnosed with medullary thyroid cancer?-An analysis of 634 patients from the California Cancer Registry.

Autor: Cox C; Department of Internal Medicine, Division of Endocrinology, University of California, Davis, USA ;, Chen Y; Department of Public Health Sciences, Division of Epidemiology, University of California, Davis, USA ;, Cress R; Department of Public Health Sciences, Division of Epidemiology, University of California, Davis, USA ;, Semrad AM; Department of Internal Medicine, Division of Endocrinology, University of California, Davis, USA ;, Semrad T; Department of Internal Medicine, Division of Hematology and Oncology, University of California, Davis, USA ;, Gosnell JE; Department of Surgery, Section of Endocrine Surgery, University of California, San Francisco, USA ;, Campbell MJ; Department of Surgery, Section of Endocrine Surgery, University of California, Davis, USA.

Publikováno v: Gland surgery [Gland Surg] 2016 Aug; Vol. 5 (4), pp. 398-404.

Zobrazit plný text záznamu

Akademický článek

The Role of Image-guided Radiotherapy in the Treatment of Anorectal Cancer Using Prone Belly-board Positioning.

Autor: Miyamoto J; Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA, U.S.A., Michaud AL; Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA, U.S.A., Harandi NK; Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA, U.S.A., Kim EJ; Division of Hematology Oncology, Department of Internal Medicine, UC Davis Comprehensive Cancer Center, Sacramento, CA, U.S.A., Semrad T; Division of Hematology Oncology, Department of Internal Medicine, UC Davis Comprehensive Cancer Center, Sacramento, CA, U.S.A., Khatri V; Division of Surgical Oncology, Department of Surgery, UC Davis Comprehensive Cancer Center, Sacramento, CA, U.S.A., Mayadev J; Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA, U.S.A., Perks J; Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA, U.S.A., Monjazeb AM; Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA, U.S.A. ammonjazeb@ucdavis.edu.

Publikováno v: Anticancer research [Anticancer Res] 2016 Jun; Vol. 36 (6), pp. 3013-7.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání